The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Viking CEO on ‘shock­ing’ mar­ket re­ac­tion to oral obe­si­ty da­ta, prepar­ing for Phase 3

6 months ago
R&D

Eu­ro­pean Com­mis­sion marks Dec. 6 for No­vo-Catal­ent deal de­ci­sion

6 months ago
Deals

Bax­ter pulls IV prod­ucts out of Chi­na to shift sup­ply to the US

6 months ago
China

WuXi in ‘ear­ly stages’ of CGT busi­ness re­view; Lon­za ex­ec be­comes AGC Bio CEO

6 months ago

Fol­low­ing March in­spec­tion, No­vo Nordisk's semaglu­tide man­u­fac­tur­ing fa­cil­i­ty cit­ed by FDA

6 months ago
FDA+

Mil­li­pore­Sig­ma in­vests €70M to triple ADC man­u­fac­tur­ing at US site 

6 months ago

WuXi AppTec is still sign­ing on new clients de­spite Biose­cure threat

6 months ago
China

Telix's new ra­dio­phar­ma spin­out banks on one tri­al for suc­cess, CEO says

7 months ago
Startups

Post-Hoc: No­vo’s obe­si­ty en­e­mies

7 months ago
Editor's note
Pharma

GSK to spend $800M to build two vac­cine fac­to­ries in the US

7 months ago

Lon­za ex­tends con­tract with un­named phar­ma; Rentschler's new build

7 months ago

Al­low­ing No­vo-Catal­ent deal to close would be ‘wrong de­ci­sion’ by an­titrust au­thor­i­ties, Roche CEO says

7 months ago
Pharma

Ther­mo Fish­er pre­dicts rev­enue uptick in 2025 as it ex­pects head­winds to ease 

7 months ago
Pharma

Sam­sung Bio inks largest deal yet worth $1.24B with un­named Asian phar­ma 

7 months ago
Deals

FDA hits Ca­mu­rus with CRL for acromegaly ther­a­py over man­u­fac­tur­ing is­sues 

7 months ago
FDA+

As­traZeneca-backed CD­MO Nu­cle­us Ra­dio­Phar­ma to boost com­mer­cial ca­pac­i­ty

7 months ago
Pharma

Catal­ent moves to re­as­sure cus­tomers about what hap­pens af­ter merg­er

7 months ago
Pharma

Con­sumer and union groups call on FTC to ‘chal­lenge’ No­vo-Catal­ent deal

7 months ago
Deals
Pharma

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the draw­ing board’

7 months ago
China
Law

Evonik winds down Ger­man site, lays off 260 work­ers; Chiesi’s €400M fa­cil­i­ty

7 months ago

Mer­ck KGaA eyes more man­u­fac­tur­ing M&A as it faces head­winds in Chi­na

7 months ago
China

Cana­di­an CD­MO broad­ens CGT foot­print with new $145M fa­cil­i­ty 

7 months ago

Ex­clu­sive: Biotech tools com­pa­ny rais­es $75M for pro­tein man­u­fac­tur­ing tech 

7 months ago
Financing

Eli Lil­ly re­veals £279M in­vest­ment in the UK through new gov­ern­ment deal

7 months ago
Deals
Pharma
First page Previous page 567891011 Next page Last page
A service from the Financial Times